Behavioral Activation for Serious Mental Illness
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new method to help individuals with serious mental illness engage more in activities and their communities. The main goal is to determine if a behavioral activation program (a type of therapy) can encourage participants to engage in more varied activities, increase community involvement, and enhance overall well-being. Individuals diagnosed with a serious mental illness, such as major depression or bipolar disorder, who feel it has impacted their daily life, might be suitable candidates. Participants will attend online sessions weekly for 10 weeks, followed by monthly sessions for an additional three months. As an unphased trial, this study provides a unique opportunity to explore new therapeutic approaches and potentially improve quality of life.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on behavioral interventions, so you may not need to change your medication routine, but it's best to confirm with the study coordinators.
What prior data suggests that this behavioral activation intervention is safe for people with serious mental illness?
Research has shown that behavioral activation is generally safe and well-tolerated. In one study, only 3.7% of participants in the behavioral activation group experienced increased suicidal thoughts, fewer than those receiving standard care. Another study found that behavioral activation can improve well-being without major issues. These findings suggest that this approach is safe for most people.12345
Why are researchers excited about this trial?
Researchers are excited about Behavioral Activation for serious mental illness because it offers a new approach through an online platform, making it more accessible than traditional in-person therapy options. Unlike standard treatments like medication or face-to-face cognitive-behavioral therapy, this method empowers individuals to engage in meaningful activities that can improve their mood and overall well-being. Additionally, the inclusion of maintenance sessions helps reinforce positive behavior changes, potentially leading to more lasting benefits.
What evidence suggests that this behavioral activation intervention is effective for serious mental illness?
Research has shown that behavioral activation can help treat depression. In several studies, participants in this therapy experienced noticeable improvements in their depression symptoms. For instance, an online group therapy program with ten sessions led to reduced depression and increased activity. In this trial, all participants will receive an online behavioral intervention for 10 weeks, followed by monthly maintenance sessions for 3 months. Behavioral activation helps individuals understand how their actions affect their feelings and encourages engagement in more positive behaviors. While most research focuses on depression, this approach also appears promising for enhancing overall well-being and involvement in meaningful activities.46789
Are You a Good Fit for This Trial?
This trial is for individuals with serious mental illnesses like Schizoaffective Disorder, Schizophrenia, various forms of Depression, Bipolar Disorder, Psychosis, and Mood Disorders. Participants should be willing to engage in online sessions and use a GPS app to track movement.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants attend a 2-hour weekly online session for 10 weeks to increase meaningful activity and community participation
Maintenance
Participants attend a 1-hour online monthly session for a 3-month maintenance period
Follow-up
Participants are monitored for safety and effectiveness after the intervention and maintenance period
What Are the Treatments Tested in This Trial?
Interventions
- Behavior Activation
Find a Clinic Near You
Who Is Running the Clinical Trial?
Temple University
Lead Sponsor
National Institute on Disability, Independent Living, and Rehabilitation Research
Collaborator